Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-86.42%
↓ 331% below average
Average (9y)
37.41%
Historical baseline
Range
High:370.72%
Low:-86.42%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -86.42% |
| 2023 | 370.72% |
| 2022 | 16.85% |
| 2021 | 2.66% |
| 2020 | -12.45% |
| 2019 | -5.40% |
| 2018 | 75.11% |
| 2017 | 0.05% |
| 2016 | -3.66% |
| 2015 | 16.64% |